Drug profile · INN
carbenicillin indanyl sodium
GEOCILLIN
carbenicillin indanyl sodium (GEOCILLIN) is a bacterial penicillin-binding protein inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — carbenicillin indanyl sodium
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
carbenicillin indanyl sodium (GEOCILLIN) is a bacterial penicillin-binding protein inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Bacterial penicillin-binding protein inhibitor
Primary target: Bacterial penicillin-binding protein
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is carbenicillin indanyl sodium?
carbenicillin indanyl sodium (GEOCILLIN) is a bacterial penicillin-binding protein inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for carbenicillin indanyl sodium?
GEOCILLIN is a marketed brand name for carbenicillin indanyl sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of carbenicillin indanyl sodium?
carbenicillin indanyl sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.